Serious adverse event

Results: 260



#Item
151Medicine / Health / Investigational New Drug / Investigational Device Exemption / Regulatory requirement / National Institute of Allergy and Infectious Diseases / Institutional review board / Data monitoring committees / Serious adverse event / Clinical research / Research / Pharmaceutical industry

DMID Protocol Template Version 3.0 28 March 2011 DMID Protocol Template Version 3.0 28 March 2011

Add to Reading List

Source URL: www.dmidcroms.com

Language: English - Date: 2014-07-03 14:41:03
152Pharmaceutical industry / Patient safety / Clinical research / Quality / Sentinel event / Adverse event / Adverse effect / Corrective and preventive action / Serious adverse event / Medicine / Health / Medical terms

Vermont State Hospital Protocol A18a Event Review Protocol Replaces Version Dated: [removed]

Add to Reading List

Source URL: mentalhealth.vermont.gov

Language: English - Date: 2013-01-30 13:14:26
153Pharmacology / Patient safety / Adverse effect / Sertraline / Antidepressant / Major depressive disorder / Serious adverse event / Pharmacovigilance / Medicine / Health / Medical terms

Microsoft PowerPoint - HCPs EN Jan 12_07.pps

Add to Reading List

Source URL: hc-sc.gc.ca

Language: English - Date: 2013-07-09 12:42:51
154Pharmaceutics / Pharmaceutical sciences / Pharmacology / Food and Drug Administration / Adverse event / ClinicalTrials.gov / Clinical trial / Serious adverse event / Pharmaceutical industry / Clinical research / Research

OCTOBER 24, 2008 ADVISORY RE CLINICAL DRUG TRIAL REPORTING To manufacturers and labelers of prescription drugs: By letter dated September 15, 2008, from Trish Riley, Director of the Governor’s Office of Health Policy

Add to Reading List

Source URL: www.maine.gov

Language: English - Date: 2011-11-29 09:00:51
155Chemistry / Food and Drug Administration / Drug safety / Medicine / Serious adverse event / Adverse event / Investigational New Drug / Methadone / Clinical research / Pharmaceutical industry / Research

NCI Contract/Grant No.______________ DCP Protocol No. ________________ IRB Protocol No. ___________________ PID No. ________________________ NCI Contract/Grant No.______________ DCP Protocol No. ________________ IRB

Add to Reading List

Source URL: prevention.cancer.gov

Language: English - Date: 2013-06-27 17:24:29
156Research / Pharmaceutical sciences / Medicine / Serious adverse event / Adverse event / Dose / Adverse effect / Clinical research / Pharmaceutical industry / Pharmacology

Adverse Event Form STUDY NAME Site Number: Pt_ID:

Add to Reading List

Source URL: www.nia.nih.gov

Language: English - Date: 2011-09-21 08:32:37
157Adverse event / Science / Business / Knowledge / Clinical research / Pharmaceutical industry / Serious adverse event

Serious Adverse Event (SAE) Report Form Protocol Title: Protocol Number: ______________________

Add to Reading List

Source URL: www.nia.nih.gov

Language: English - Date: 2012-01-09 08:25:45
158Pharmaceutical industry / Alternative medicine / Chiropractic treatment techniques / Osteopathy / Chiropractic / Spinal manipulation / Adverse event / Serious adverse event / Medicine / Health / Clinical research

Canadian Paediatric Surveillance Program Survey Adverse events associated with paediatric complementary and alternative medicine An increasing number of Canadian children use “complementary and alternative medicine”

Add to Reading List

Source URL: www.cpsp.cps.ca

Language: English - Date: 2012-10-22 14:28:51
159Research / Technology / Medical equipment / Pharmacology / Global Harmonization Task Force / Adverse event / Clinical trial / Serious adverse event / Medical device / Clinical research / Pharmaceutical industry / Medicine

Reportable Events During Pre-Market Clinical Investigations Study Group 5 Final Document GHTF/SG5/N5:2012 Reportable Events During Pre-Market Clinical Investigations Study Group 5 Final Document GHTF/SG5/N5:2012

Add to Reading List

Source URL: www.imdrf.org

Language: English - Date: 2012-11-13 17:53:15
160Eli Lilly and Company / Antifolates / Benzamides / Pemetrexed / Mesothelioma / Lung cancer / Food and Drug Administration / Medicine / Health / Oncology

Justified Abbreviated Presentation Criteria MOST of the following criteria are met: •Little if any use • Not marketed • No deaths OR deaths because of underlying disease • Few if any serious adverse event (SAE) r

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE